The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib treatment (Tx) in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) by BRCA mutation (BRCAm) and homologous recombination deficiency (HRD) status: Overall survival (OS) results from the phase II LIGHT study.
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Deciphera (Inst); Moderna Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
Fiona Simpkins
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Instil Bio (Inst); Sierra Oncology (Inst)
 
Karen Anne Cadoo
Honoraria - OncLive
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; GlaxoSmithKline/Tesaro; MJH Life Sciences; MSD
Research Funding - AstraZeneca (Inst); MSD (Inst); Syndax (Inst)
 
Ying L Liu
Research Funding - AstraZeneca; Tesaro/GSK
 
Diane M. Provencher
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - Abbvie; AstraZeneca
 
Colleen McCormick
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck
Speakers' Bureau - AstraZeneca
 
Adam ElNaggar
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Merck; Tesaro/GSK
Research Funding - AstraZeneca; Caris Life Sciences; Tesaro/GSK
 
Alon D Altman
Honoraria - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck; Pfizer
Other Relationship - Merck
 
Lucy Gilbert
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck
Consulting or Advisory Role - GlaxoSmithKline; Merck
Research Funding - Alkermes (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); IMV (Inst); Inovio Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; Pfizer
 
Destin Black
No Relationships to Disclose
 
Nashwa Kabil
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
James Bennett
Employment - AstraZeneca
 
Jiefen Munley
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Judy Yu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Carol Aghajanian
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; Eisai; Eisai; Mersana; Repare Therapeutics; Roche; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst)